Horizon Technology Finance Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

false 0001487428 0001487428 2025-05-23 2025-05-23 0001487428 hrzn:CommonStockParValue0001PerShareCustomMember 2025-05-23 2025-05-23 0001487428 hrzn:NotesDue20264875CustomMember 2025-05-23 2025-05-23 0001487428 hrzn:NotesDue2027625CustomMember 2025-05-23 2025-05-23

 

 

 

 

 

(Exact name of registrant as specified in its charter)

 

 

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (860) 676-8654

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

On May 23, 2025 (the “2025 Amendment Date”), Horizon Funding II, LLC (the “Issuer”), a Delaware limited liability company and wholly owned subsidiary of Horizon Technology Finance Corporation (the “Company”), executed that certain First Supplemental Indenture by and among the Issuer and U.S. Bank Trust Company, National Association (the “Trustee”) (the “First Supplemental Indenture”), which amended that certain Indenture by and among the Issuer, the Trustee and U.S. Bank National Association (“U.S. Bank”), dated as of June 21, 2024 (the “Indenture”). The First Supplemental Indenture extended the “Legal Final Payment Date” to June 2034. Concurrently, the Issuer entered into that certain Amended and Restated Note Funding Agreement by and among the Issuer and the initial purchasers (the “A&R Note Funding Agreement”), which. among other things, increased the commitment amount to $200,000,000. In addition, the Company entered into that certain Amendment No. 1 to Sale and Servicing Agreement by and among the Issuer, the Company, the Trustee and U.S. Bank (the “Amendment No. 1”), which amended that certain Sale and Servicing Agreement by and among the Issuer, the Company, the Trustee and U.S. Bank, dated as of June 21, 2024 (the “Sale and Servicing Agreement”). The Amendment No. 1, among other things, (1) amended the interest rate for borrowings made after the 2025 Amendment Date, fixing the interest rate at the greater of (i) 5.00% and (ii) the Pricing Benchmark (as defined therein) plus 2.95%, (2) added a new excess concentration amount for loans with a six (6) year term, (3) extended the term of the investment period termination date from June 21, 2027 to June 21, 2028 and (4) extended the “Legal Final Payment Date” to June 2034.

 

The description of the documentation related to the A&R Note Funding Agreement, the Amendment No. 1 and the First Supplemental Indenture contained in this Current Report on Form 8-K is only a summary of the material terms of the A&R Note Funding Agreement, the Amendment No. 1 and the First Supplemental Indenture and are qualified in their entirety by the terms of the A&R Note Funding Agreement, the Amendment No. 1 and the First Supplemental Indenture filed as exhibits hereto, which is incorporated herein by reference.

 

 

(d) Exhibits.

   

2

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

3